このエントリーをはてなブックマークに追加
ID 65299
FullText URL
Author
Shigehira, Takafumi Department of Cellular Physiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Hanafusa, Tadashi Neutron Therapy Research Center, Okayama University ORCID Kaken ID publons researchmap
Igawa, Kazuyo Neutron Therapy Research Center, Okayama University Kaken ID researchmap
Kasai, Tomonari Neutron Therapy Research Center, Okayama University
Furuya, Shuichi Research Laboratory of Accelerator-Based BNCT system, Graduate School of Engineering Nagoya University
Nishimori, Hisakazu Department of Hematology and Oncology Okayama University Hospital Okayama Okayama 700–8558 Japan
Maeda, Yoshinobu Department of Hematology and Oncology, Okayama University Hospital Kaken ID researchmap
Michiue, Hiroyuki Neutron Therapy Research Center, Okayama University
Fujimura, Atsushi Department of Cellular Physiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences ORCID Kaken ID researchmap
Abstract
Boron neutron capture therapy (BNCT) is a radiation therapy that selectively kills cancer cells at the cellular level using the boron neutron capture reaction (BNCR) (10B(n.α)7Li). The amount of boron 10B delivers in boronophenylalanine (BPA)-BNCT to achieve anti-tumor effects is ≈15–40 ppm. The same is true for all boron drugs; however, whether the same amount of 10B is required for other boron drugs with different accumulation characteristics has not been intensively investigated. Therefore, herein, a virtual cell model with intracellular organelles is prepared, and the BPA equivalent dose concentration to the cell nucleus is analyzed using particle and heavy ion transport code system-based microdosimetry. Additionally, the intranuclear minimal region (IMR) is set as a reference for the concept of the intranuclear domain in the microdosimetric kinetic model, and the BPA equivalent dose concentration to the IMR is estimated. The required boron delivery dose greatly varies depending on the dose assessment based on the accumulation characteristics of boron agents in intracellular organelles. Evaluation of the BNCR effect according to the accumulation characteristics without being influenced by the specified value of 15–40 ppm is recommended.
Keywords
boron agents
boron neutron capture therapy
simulation study
Note
This is the peer reviewed version of the following article: T. Shigehira, T. Hanafusa, K. Igawa, T. Kasai, S. Furuya, H. Nishimori, Y. Maeda, H. Michiue, A. Fujimura, Particle and Heavy Ion Transport Code System-Based Microdosimetry for the Development of Boron Agents for Boron Neutron Capture Therapy. Adv. Theory Simul. 2023, 6, 2300163. https://doi.org/10.1002/adts.202300163, which has been published in final form at https://doi.org/10.1002/adts.202300163. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. This article may not be enhanced, enriched or otherwise transformed into a derivative work, without express permission from Wiley or by statutory rights under applicable legislation. Copyright notices must not be removed, obscured or modified. The article must be linked to Wiley’s version of record on Wiley Online Library and any embedding, framing or otherwise making available the article or pages thereof by third parties from platforms, services and websites other than Wiley Online Library must be prohibited.
This fulltext file will be available in Apr. 2024.
Published Date
2023-04-28
Publication Title
Advanced Theory and Simulations
Volume
volume6
Issue
issue7
Publisher
Wiley
Start Page
2300163
ISSN
2513-0390
Content Type
Journal Article
language
English
OAI-PMH Set
岡山大学
Copyright Holders
© 2023 Wiley-VCH GmbH
File Version
author
DOI
Web of Science KeyUT
Related Url
isVersionOf https://doi.org/10.1002/adts.202300163
Citation
T. Shigehira, T. Hanafusa, K. Igawa, T. Kasai, S. Furuya, H. Nishimori, Y. Maeda, H. Michiue, A. Fujimura, Particle and Heavy Ion Transport Code System-Based Microdosimetry for the Development of Boron Agents for Boron Neutron Capture Therapy. Adv. Theory Simul. 2023, 6, 2300163. https://doi.org/10.1002/adts.202300163
Funder Name
Japan Society for the Promotion of Science
助成番号
JP21K07730